# EDGAR Filing Document

**Accession Number:** 0002096900
**File Stem:** 0001213900-26-018105
**Filing Date:** 2026-2
**Character Count:** 9465
**Document Hash:** a0d9cf0060ab8268023dbaaab643f980
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-018105.hdr.sgml**: 20260218

**ACCESSION NUMBER**: 0001213900-26-018105

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260218

**FILED AS OF DATE**: 20260218

**DATE AS OF CHANGE**: 20260218

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** BERRY DAVID A
- **CENTRAL INDEX KEY:** 0001204876

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-43135
- **FILM NUMBER:** 26650988

**MAIL ADDRESS:**
- **STREET 1:** C/O ELEVEN BIOTHERAPEUTICS, INC.
- **STREET 2:** 215 FIRST STREET, SUITE 400
- **CITY:** CAMBRIDGE
- **STATE:** MA
- **ZIP:** 02142
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Averin Capital Acquisition Sponsor LLC
- **CENTRAL INDEX KEY:** 0002108995

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-43135
- **FILM NUMBER:** 26650989

**BUSINESS ADDRESS:**
- **STREET 1:** 240 W 40TH STREET OFFICE 205
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10018
- **BUSINESS PHONE:** 339-234-9160

**MAIL ADDRESS:**
- **STREET 1:** 240 W 40TH STREET OFFICE 205
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10018
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Handel Rose LLC
- **CENTRAL INDEX KEY:** 0002108994

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-43135
- **FILM NUMBER:** 26650987

**BUSINESS ADDRESS:**
- **STREET 1:** 240 W 40TH STREET OFFICE 205
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10018
- **BUSINESS PHONE:** 339-234-9160

**MAIL ADDRESS:**
- **STREET 1:** 240 W 40TH STREET OFFICE 205
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10018
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Averin Capital Acquisition Corp.
- **CENTRAL INDEX KEY:** 0002096900
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 981891461
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 9 BARTLET ST. STE 137
- **CITY:** ANDOVER
- **STATE:** MA
- **ZIP:** 01810
- **BUSINESS PHONE:** 339-234-9160

**MAIL ADDRESS:**
- **STREET 1:** 9 BARTLET ST. STE 137
- **CITY:** ANDOVER
- **STATE:** MA
- **ZIP:** 01810

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Averin Capital Acquisition Sponsor LLC<br><sub>(Last) (First) (Middle)</sub><br>C/O AVERIN CAPITAL ACQUISITION CORP.<br>240 W 40TH STREET, OFFICE 205<br><sub>(Street)</sub><br>NEW YORK, NY 10018<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Averin Capital Acquisition Corp. [ ACAAU ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-02-18 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [X] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>BERRY DAVID A<br><sub>(Last) (First) (Middle)</sub><br>C/O AVERIN CAPITAL ACQUISITION CORP.<br>240 W 40TH STREET, OFFICE 205<br><sub>(Street)</sub><br>NEW YORK, NY 10018<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Averin Capital Acquisition Corp. [ ACAAU ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-02-18 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Chief Executive Officer_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Handel Rose LLC<br><sub>(Last) (First) (Middle)</sub><br>C/O AVERIN CAPITAL ACQUISITION CORP.<br>240 W 40TH STREET, OFFICE 205<br><sub>(Street)</sub><br>NEW YORK, NY 10018<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Averin Capital Acquisition Corp. [ ACAAU ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-02-18 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [X] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Class B Ordinary Shares, par value $0.0001 per share<sup>(1)</sup> | <sup>(1)</sup> | <sup>(1)</sup> | Class A Ordinary Shares, par value $0.0001 per share | 7387500<sup>(2)</sup> | <sup>(1)</sup> | D<sup>(2)(3)</sup> |  |

---

### Footnotes:

(1) As described in the registration statement on Form S-1 (File No. 333-293082) of Averin Capital Acquisition Corp. (the "Issuer") under the heading "Description of Securities," the shares of Class B ordinary shares will automatically convert into shares of Class A ordinary shares at the time of the Issuer's initial business combination, or at any time prior to the Issuer's initial business combination, at the option of the holder, on a one-for-one basis, subject to certain adjustments. The Class B ordinary shares have no expiration date.

(2) These shares represent the Class B ordinary shares held by Averin Capital Acquisition Sponsor LLC (the "Sponsor") acquired pursuant to a subscription agreement by and between the Issuer and the Sponsor. The Class B ordinary shares include up to 937,500 shares that are subject to forfeiture in the event the underwriters of the Issuer's initial public offering do not exercise in full their over-allotment option as described in the Issuer's registration statement.

(3) Represents shares held by Averin Capital Acquisition Sponsor LLC. Handel Rose LLC, is the sole managing member of the Sponsor and controls the management of the Sponsor, including the exercise of voting and investment discretion over the securities of the Issuer held by the Sponsor. Eric Berry and David Berry are the managers of Handel Rose LLC. David Berry and Eric Berry both may be deemed to beneficially own 7,387,500 Class B Ordinary Shares and ultimately exercise voting and dispositive power of the securities held by the Sponsor. Each such person disclaims any beneficial ownership of the securities reported herein other than to the extent of any pecuniary interest they may have therein, directly or indirectly.

**Signature:** /s/ Averin Capital Acquisition Sponsor LLC, By: Handel Rose LLC, its Managing Member, By: /s/ David Berry, Name: David Berry, Title: Manager  
**Date:** 2026-02-18

**Signature:** /s/ David Berry  
**Date:** 2026-02-18

**Signature:** /s/ Handel Rose LLC, By: David Berry, Managing Member  
**Date:** 2026-02-18

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**